NOS3 and open-angle glaucoma: Our findings suggest that NOS3 polymorphism(s) may be a significant genetic biomarker in POAG and provides an additional evidence to support the hypothesis that reduced NO (or enhanced oxidative stress) may play a vital role in the pathogenesis of POAG.